| Literature DB >> 35411185 |
Anna Marie Balestra1, Katharina Chalk1, Claudia Spies1, Claudia Denke1, Henning Krampe1, Sascha Tafelski1.
Abstract
Purpose: COVID-19 pandemic containment measures have led to changes in various areas of life, including restrictions on health care. Patients with chronic pain may have faced an increased burden during pandemic and the resources of this vulnerable population are unknown. Therefore, a qualitative study was conducted to understand how people with chronic pain have experienced the course of the pandemic. Patients andEntities:
Keywords: COVID-19 pandemic; chronic pain; coping; mental distress; telemedicine
Year: 2022 PMID: 35411185 PMCID: PMC8994632 DOI: 10.2147/JPR.S351846
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Demographic and Clinical Characteristics of the Sample (N=20)a
| Variable | N=20 Patients |
|---|---|
| Female gender | 12 (60) |
| Age in years | 57.5 [54.75; 73.25] |
| Years of pain | 18.5 [8; 30] |
| In a partnership | 14 (70) |
| Living alone | 7 (35) |
| Occupational status | |
| Employed | 10 (50) |
| Not employed (retired, disabled, unemployed) | 10 (50) |
| Highest level of education | |
| Secondary educationb | 7 (35) |
| Postsecondary educationc | 13 (65) |
| Chronic pain syndromes | |
| Musculoskeletal pain | 13 (65) |
| Neuropathic pain | 12 (60) |
| Rheumatic disease | 7 (35) |
| Back pain | 8 (40) |
| Abdominal pain | 7 (35) |
| Orofacial pain | 1 (5) |
| Other diseases | |
| Depression | 7 (35) |
| Cardiovascular disease | 10 (50) |
| Metabolic disease/hormonal disorder | 10 (50) |
| Lung disease | 2 (10) |
| Tumor disease | 5 (25) |
Notes: aData are given as numbers (%) or medians [25–75% quartiles]. bISCED 2011 Levels 4 and 5.24 cISCED 2011 Levels 6 and 7.24
Figure 1Summary of findings from the qualitative analysis on the experiences of the COVID-19 pandemic by people with chronic pain disease.